SA

Suresh Arvindbhai Hirani

Active Director Director DIN 09745904
DIN 09745904 First appointment Sep 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Suresh Arvindbhai Hirani

Data last updated:

Suresh Arvindbhai Hirani is a Director at Dholavira Healthcare Private Limited (since 2022). The company operates in Chemicals.

DIN 09745904
Primary Designation Director
Industry Chemicals
First Appointment 22 Sep 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dholavira Healthcare Private Limited U24239GJ2022PTC135688
Director22 Sep 20222022Active

Board colleagues of Suresh Arvindbhai Hirani

NameDINCompanyDesignation
Paresh Arvind Hirani09745903Dholavira Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dholavira Healthcare Private Limited
Premium access

Shareholding and investment profile for Suresh Arvindbhai Hirani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Arvindbhai Hirani

Suresh Arvindbhai Hirani currently holds 1 directorship: Dholavira Healthcare Private Limited (Director, since 22 Sep 2022).

Suresh Arvindbhai Hirani was first appointed on 22 Sep 2022 as Director at Dholavira Healthcare Private Limited.

The current boards of Suresh Arvindbhai Hirani's companies include Paresh Arvind Hirani (Dholavira Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available